Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
Iambic has raised $66.0M in total funding. The most recent round was Debt Financing. The last funding was announced in September 2026.
Iambic's investors include Alumni Ventures, NVIDIA, Sequoia Capital, Catalio Capital Management, Nexus Venture Partners.
Iambic is headquartered in San Diego, United States.
Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.
Iambic is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iambic — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/iambic-san-diego. Accessed October 21, 2026.
VCBacked. (2026). Iambic — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/iambic-san-diego
{{cite web |title=Iambic — Funding & Investors |url=https://www.vcbacked.co/company/iambic-san-diego |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated